- News and more from the frontiers of medicine
To make the most of medical innovation at a time when society’s expectations about healthcare are rapidly changing, Novartis is reimagining medicine.
The future of Novartis
Our future is as a leading focused medicines company, powered by data science and advanced therapy platforms. CEO Vas Narasimhan shares our vision.
Alcon becomes a separately traded standalone company
On April 9, 2019 Alcon becomes a separately traded company. Novartis and Alcon are now positioned to capitalize on significant growth opportunities and focus resources on their respective businesses and strategic priorities.